Skip to content

Outcomes of liver and pancreatic caner surgery during the COVID-19 pandemic

COVID-IHPBA: A snapshot study on the outcomes of hepatobiliary and pancreatic surgery during the COVID-19 pandemic: an international, multicentre, observational cohort study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/08/027466
Enrollment
1000
Registered
2020-08-29
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

None listed

Sponsors

Tata Memorial Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Adults age more than equal to 18 years with a confirmed diagnosis requiring HPB surgery, both benign and malignant 2) Cholecystectomy will be included as ââ?¬Å?basicââ?¬? HPB surgery with very low morbidity and almost null mortality.

Exclusion criteria

Exclusion criteria: 1) HPB Surgery performed in the trauma setting. 2) HPB Surgery performed as a synchronous case with another specialty ââ?¬â?? e.g. synchronous colonic and liver resections. 3) Liver transplantation

Design outcomes

Primary

MeasureTime frame
To evaluate the outcomes in all patients undergoing hepatobiliary and pancreatic HPB surgery outside liver or pancreas transplantations during the COVID-19 pandemic.Timepoint: 6 month

Secondary

MeasureTime frame
-To assess the 30-day postoperative mortality rate in HPB surgery patients that develop pre- or postoperatively COVID-19 infection. -To evaluate HPB-specific complications, as defined by a variety of HPB working groups, occurring in HPB surgery patients during the COVID-19 pandemic. -To evaluate if the COVID-19 pandemic has altered the decision making to proceed with HPB surgery Timepoint: 6 month

Countries

France, Germany, India, Ireland, United States of America

Contacts

Public ContactShailesh V Shrikhande

Tata Memorial Hospital

shailushrikhande@hotmail.com9820224761

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026